Action 4188 AMCAD BIOMED CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues AmCad BioMed Corporation

Actions

4188

TW0004188008

Cours en clôture Taipei Exchange
Autres places de cotation
 00:00:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
26,35 TWD +1,15% Graphique intraday de AmCad BioMed Corporation +0,76% -1,31%
09/05 AmCad BioMed Corporation annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
29/02 AmCad BioMed Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
PsiQuantum, Corp., Mitsubishi UFJ Financial Group, Inc. and Mitsubishi Chemical Announces Partnership to Design Energy-Efficient Materials on PsiQuantum?s Fault-Tolerant Quantum Computer
AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AmCad BioMed Corporation Announces Management Changes
AmCad BioMed Corporation Approves Board Changes
AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
AmCad Biomed Corporation Appoints Maureen Chang as Corporate Governance Officer
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
AmCad BioMed : BOD approve the 2022 second quarter consolidated financial statements
AmCad BioMed : is invited to Online Investor Conference held by KGI Securities
AmCad BioMed : On behalf of our subsidiary Broadsound Co., we announce the major resolutions of 2022 Annual General Shareholders' Meeting.
AmCad BioMed : The major resolutions of 2022 Annual General Shareholders' Meeting.
AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
AmCad BioMed : Announcing termination of private equity offering which was approved by 2021 Annual Shareholders' Meeting.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 4188
  4. Actualités AmCad BioMed Corporation
  5. Autres langues